Rasagiline
- Product NDC
- 62135-676
- 11-digit product format
- 621350676
- Labeler code
- 62135
- Product ID
- 62135-676_17dd92b2-969b-16f1-e063-6394a90aee89
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Rasagiline
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Chartwell RX, LLC
- Application
- ANDA201892
- Marketing category
- ANDA
- Marketing start
- 2018-07-27
- Substance
- RASAGILINE MESYLATE
- Active strength
- .5 mg/1
- Pharmacologic classes
- Monoamine Oxidase Inhibitor [EPC], Monoamine Oxidase Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Rasagiline
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| RASAGILINE MESYLATE | .5 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | LH8C2JI290 |
| Rxcui | 608328, 636664 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 62135-676-30 | Rasagiline | 30 in 1 BOTTLE | TABLET | 30 | | 1 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 62135-676 | RASAGILINE TABLET [CHARTWELL RX, LLC] | 1 | Current NDC, 1 package rows | 20240508_d9168d62-814a-444f-9d70-11674def339d.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|
| 62135-676-30 | 62135067630 | 30 TABLET in 1 BOTTLE (62135-676-30) | 30 tablet | 2024-05-01 | No | No | Current |